Poor sleep may affect cognitive abilities and behavior of children with kidney disease

November 07, 2019

Washington, DC (November 7, 2019) -- Sleep problems and fatigue may affect the cognitive function of children with chronic kidney disease. The findings come from a study that will be presented at ASN Kidney Week 2019 November 5-November 10 at the Walter E. Washington Convention Center in Washington, DC.

Children with chronic kidney disease face a higher risk for experiencing neurocognitive deficits. To examine whether sleep problems or fatigue may play a role, Rebecca Johnson, PhD (Children's Mercy Kansas City) and her colleagues examined clinical trial data related to fatigue, sleep disturbance, low energy, and trouble sleeping in 1,030 children with mild-to-moderate chronic kidney disease.

Among the children in the study, 26% experienced fatigue, 30% reported sleep disturbances, 39% experienced trouble sleeping, and 52% had low energy. Sleep disturbance, trouble sleeping, and low energy were significantly associated with worse parent ratings of overall executive functions (cognitive processes responsible for control of behavior, such as attentional control, inhibition, working memory, and cognitive flexibility). Fatigue and sleep problems were also associated with more parent-reported emotional and behavioral symptoms.  

"Fatigue and sleep problems are prevalent among children with chronic kidney disease and may affect neurocognitive and emotional-behavioral functioning," said Dr. Johnson. "Assessment of sleep problems and fatigue, interventions to improve sleep, and treating medical co-morbidities may promote more positive emotional-behavioral and neurocognitive outcomes for children with chronic kidney disease."
-end-
Study: "Sleep Problems and Fatigue and their Relationships with Emotional-behavioral Symptoms and Neurocognitive Outcomes in Pediatric CKD"

ASN Kidney Week 2019, the largest nephrology meeting of its kind, will provide a forum for more than 13,000 professionals to discuss the latest findings in kidney health research and engage in educational sessions related to advances in the care of patients with kidney and related disorders. Kidney Week 2019 will take place November 5 - November 10 in Washington, DC.

Since 1966, ASN has been leading the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients. ASN has more than 20,000 members representing 131 countries. For more information, please visit http://www.asn-online.org or contact the society at 202-640-4660.

American Society of Nephrology

Related Chronic Kidney Disease Articles from Brightsurf:

How to ensure patients manage their chronic kidney disease
A Singapore study finds patients with chronic kidney disease need tailored nutrition guidance, as well as better communication with doctors and family support, to empower them to manage their condition.

Children with chronic kidney disease have outsized health burden
Chronically ill children with kidney disease may spend more time in the hospital, incur larger health care costs and have a higher risk of death compared to pediatric patients hospitalized for other chronic conditions, a new study suggests.

Your neighborhood may raise your risk of chronic kidney disease
A neighborhood's overall socioeconomic status, including income and education-level, may influence its residents' risk of chronic kidney disease, according to a study recently published in SSM Population Health by researchers from Drexel University's Dornsife School of Public Health.

These lifestyle choices can reduce the risk of chronic kidney disease
Active lifestyle choices such as eating vegetables, exercising and quitting smoking can reduce the risk of chronic kidney disease, a new study led by researchers at Karolinska Institutet in Sweden and Griffith University in Australia, reports.

SGLT2 inhibitors can slow progression of chronic kidney disease
The CREDENCE trial [3] provided evidence that the SGLT2 inhibitor Canagliflozin slows the progression of CKD in individuals with type 2 diabetes (T2D) and CKD with albuminuria.

Antioxidant agent may prevent chronic kidney disease and Parkinson's disease
Researchers from Osaka University developed a novel dietary silicon-based antioxidant agent with renoprotective and neuroprotective effects.

New study provides insight into chronic kidney disease
Researchers have further analyzed a known signaling pathway they believe brings them one step closer to understanding the complex physiology of patients with chronic kidney disease (CKD), which might provide a path to new treatment options.

Predicting risk of chronic kidney disease
Data from about 5 million people (with and without diabetes) in 28 countries were used to develop equations to help identify people at increased five-year risk of chronic kidney disease, defined as reduced estimated glomerular filtration rate (eGFR).

New tool predicts five-year risk of chronic kidney disease
A new risk calculator tool that uses a mix of variables including age, hypertension, and diabetes status can be used to predict accurately whether someone is likely to develop chronic kidney disease within five years.

Gap in care found for patients with chronic kidney disease: study
Millions of Canadians living with chronic kidney disease (CKD) may be going without critical testing from their primary care practitioners that would give them a good idea of the severity of the disease so they could intervene earlier with more appropriate care, according to a new study.

Read More: Chronic Kidney Disease News and Chronic Kidney Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.